🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The new drug pyrifazimine (previous name: TBI-166) developed by the Institu...
Status
Unknown
Location
Beijing Chest Hospital
Start Date
2021-03-01
Trial ID
NCT04670120
Treatments Being Tested
This is a prospective, randomized, parallel, controlled study comparing the...
Status
Completed
Location
Guangzhou Chest Hospital
Start Date
2009-03
Trial ID
NCT01618422
Treatments Being Tested
Globally, tuberculosis (TB) is one of the main causes of death and the lead...
Status
Completed
Location
Icddr,B
Start Date
2025-02-28
Trial ID
NCT05845112
Treatments Being Tested
The goal of this observational study is to evaluate the implementation of t...
Status
Recruiting
Location
Hospital das Clínicas da Faculdade de Medicina de Botucatu
Start Date
2024-04-16
Trial ID
NCT06673225
Treatments Being Tested
Mycobacterium tuberculosis (Mtb) is a major human pathogen, responsible for...
Status
Enrolling By Invitation
Location
Infectious diseases institute, Makarere University
Start Date
2024-09-30
Trial ID
NCT06751706
Chronic obstructive pulmonary disease (COPD) still imposes a substantial he...
Status
Unknown
Location
Peking University Third Hospital
Start Date
2024-05-01
Trial ID
NCT06074042
Treatments Being Tested
Introduction: The monitoring of respiratory patterns is crucial in the mana...
Status
Active Not Recruiting
Location
Emergency Care Unit from Engenho Velho
Start Date
2025-08-18
Trial ID
NCT07164586
Treatments Being Tested
Lung cancer is the leading cause of mortality in the world, and also in Tai...
Status
Recruiting
Location
Chung Shan Medical University
Start Date
2022-12-15
Trial ID
NCT05557487
Treatments Being Tested
This is an open label randomized controlled clinical trial comparing two re...
Status
Completed
Location
CAPRISA eThekwini Clinical Research Site (eCRS)
Start Date
2013-11
Trial ID
NCT02114684
Treatments Being Tested
To characterise the innate pulmonary immune response and respiratory microb...
Status
Recruiting
Location
Churchill Hospital
Start Date
2024-08-15
Trial ID
NCT06526689